Results 31 to 40 of about 1,675 (195)

Management of PTLD After Hematopoietic Stem Cell Transplantation: Immunological Perspectives

Frontiers in Immunology, 2020
Post-transplant lymphoproliferative disorders (PTLDs) are life-threatening complications of iatrogenic immune impairment after allogeneic hematopoietic stem cell transplantation (HSCT).
Francesca Compagno, Sabrina Basso, Sabrina Basso, Arianna Panigari, Jessica Bagnarino, Jessica Bagnarino, Luca Stoppini, Luca Stoppini, Alessandra Maiello, Alessandra Maiello, Tommaso Mina, Paola Zelini, Paola Zelini, Cesare Perotti, Fausto Baldanti, Marco Zecca, Patrizia Comoli, Patrizia Comoli   +17 more
doaj   +1 more source

Borreliella burgdorferi Antimicrobial-Tolerant Persistence in Lyme Disease and Posttreatment Lyme Disease Syndromes

mBio, 2022
The annual incidence of Lyme disease, caused by tick-transmitted Borreliella burgdorferi, is estimated to be at least 476,000 cases in the United States and many more worldwide.
Felipe C. Cabello, Monica E. Embers, Stuart A. Newman, Henry P. Godfrey   +3 more
doaj   +1 more source

Health care costs, utilization and patterns of care following Lyme disease.

PLoS ONE, 2015
BackgroundLyme disease is the most frequently reported vector borne infection in the United States. The Centers for Disease Control have estimated that approximately 10% to 20% of individuals may experience Post-Treatment Lyme Disease Syndrome - a set of
Emily R Adrion, John Aucott, Klaus W Lemke, Jonathan P Weiner   +3 more
doaj   +1 more source

Diagnosis and treatment of “chronic Lyme”: primum non nocere

BMC Infectious Diseases, 2023
Background Approximately 10% of patients experience prolonged symptoms after Lyme disease. PTLDS (post treatment Lyme disease syndrome) is a controversial topic. It has been described as a source of overdiagnosis and off-label treatment. This review aims
Prat Sébastien, Dalbin Jacques, Plotton Catherine, Gocko Xavier   +3 more
doaj   +1 more source

Equal-opportunity treatment of EBV-PTLD [PDF]

Blood, 2012
In 1994, investigators at the Memorial Sloan-Kettering Cancer Center described the first successful use of donor lymphocyte infusion (DLI) to treat Epstein-Barr virus (EBV) after transplantation lymphoproliferative disorder (PTLD) after hemopoietic stem cell transplantation (HSCT).
openaire   +2 more sources

Chronotropic Intolerance In Patients With Chronic Lyme Disease Identified By Serial Cardiopulmonary Exercise Testing

, 2020
In the U.S., annual incidence of Lyme disease is approximately 300,000. In an estimated 5-30% of cases, post-treatment Lyme disease syndrome (PTLDS) develops; symptoms include post-exertional malaise characteristic of myalgic encephalomyelitis.
J. Mark VanNess, Stevens, Jared, Staci Stevens, Courtney D. Jensen, Todd Davenport, Mohan, Saejel G., Davenport, Todd E., Jared Stevens, Jensen, Courtney D., Van Ness, J. Mark, Saejel G. Mohan, Stevens, Staci   +11 more
core   +1 more source

Posttransplant lymphoproliferative disorder in renal transplant recipients: Experience from a Tertiary Care Center

Saudi Journal of Kidney Diseases and Transplantation, 2021
Posttransplant lymphoproliferative disorders (PTLDs) are potentially fatal complications arising after solid organ or hematopoietic stem cell transplant.
Devika Gupta, Satish Mendonca, Rohit Tewari, Ankur Ahuja, Lavan Singh, Arun Joshi, Tathagata Chatterjee   +6 more
doaj   +1 more source

Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients

, 2009
Post-transplant lymphoproliferative disorders (PTLDs) represent a frequent complication of solid organ transplantation. Although most PTLDs arise from recipient lymphoid cells, a considerable fraction of cases may arise from donor B-cells.
Morra E, Rasi S, Cerri M, Colosimo A, ROSSI, Davide, Muti G, Ravelli E, Gambacorta M, Oreste P, CAPELLO, Daniela, Veronese S, GAIDANO, Gianluca, Minola E   +12 more
core   +1 more source

Efficacy and safety of antibiotic therapy for post-Lyme disease? A systematic review and network meta-analysis

BMC Infectious Diseases, 2023
Background At present, the pathogenesis of post-treatment Lyme disease (PTLDS) is not clear, so the treatment scheme of PTLDS, especially antibiotic treatment, is still controversial.
Xiaoqian Zhang, Yuwei Jiang, Yihan Chen, Jiaru Yang, Xiaoqi Zhang, Lu Xing, Aihua Liu, Fukai Bao   +7 more
doaj   +1 more source

Post‐Tuberculosis Lung Disease: Clinicopathologic Insights, Diagnosis, Prevention, and Management

MedComm, Volume 7, Issue 10, October 2026.
A comprehensive review on post‐tuberculosis lung disease (PTLD) addresses the epidemiology, pathogenesis, clinical phenotypes and management, risk factors, prevention and systems approach, and future directions. This review provides standardized definitions, mechanistic insights and biomarkers of PTLD development, and clinical strategies for PTLD ...
Radha Gopalaswamy, Selvakumar Subbian
wiley   +1 more source